Literature DB >> 22875651

Health related quality of life in Mexican women with systemic lupus erythematosus: a descriptive study using SF-36 and LupusQoL(C).

M García-Carrasco1, C Mendoza-Pinto, M H Cardiel, S Méndez-Martínez, A García-Villaseñor, C Jiménez-Hernández, N E Alonso-García, R Briones-Rojas, G Ramos-Álvarez, A López-Colombo.   

Abstract

The LupusQoL© questionnaire is a disease-specific health related quality of life (HRQOL) instrument for adults with systemic lupus erythematosus (SLE). The Short Form-36 (SF-36) is a generic instrument that captures the physical, psychological, and social impact. We conducted a descriptive study of women aged ≥ 18 years attending our Lupus Clinic. HRQOL was assessed by applying the LupusQoL© and SF-36. Lupus activity was measured using the Mexican Systemic Lupus Erythematosus Disease Activity Index (Mex-SLEDAI) and chronic damage using the Systemic Lupus Collaborative Clinics Damage Index (SDI). Data were analyzed using descriptive statistics, the chi-square test and Pearson's product moment correlation coefficient. A total of 127 patients were included with a mean age of 40.5 ± 12.6 years. The mean disease duration was 8.2 ± 5.6 years, the mean disease activity score was 2.4 ± 3.0, and the mean SDI score 0.77 ± 1.06. The mean SF-36 score was 58.1 ± 21.1 and the mean LupusQoL© score was 69 ± 22.7. The correlation between global scores of the SF-36 and LupusQoL© was rho = 0.73 (p < 0.001). The correlation between lupus disease activity and the SF-36 and the LupusQoL© was -0.26 (p = 0.003) and -0.25 (p = 0.004), respectively. The correlation between the SDI and the SF-36 and the LupusQoL© was -0.28 (p = 0.001) and -0.38 (p < 0.0001), respectively. In conclusions: both LupusQoL© and SF-36 were useful instruments in assessing HRQOL in Mexican lupus female patients. The usefulness of the LupusQoL© should be evaluated in lupus patients with moderate to severe disease activity.

Entities:  

Mesh:

Year:  2012        PMID: 22875651     DOI: 10.1177/0961203312456749

Source DB:  PubMed          Journal:  Lupus        ISSN: 0961-2033            Impact factor:   2.911


  9 in total

1.  Health-related quality of life assessed by LupusQoL questionnaire and SF-36 in Turkish patients with systemic lupus erythematosus.

Authors:  Sibel Yilmaz-Oner; Can Oner; Fatih Mert Dogukan; Toklong Filam Moses; Kubra Demir; Nazar Tekayev; Pamir Atagunduz; Serhan Tuglular; Haner Direskeneli
Journal:  Clin Rheumatol       Date:  2015-04-07       Impact factor: 2.980

Review 2.  Living with systemic lupus erythematosus in the developing world.

Authors:  A Phuti; M Schneider; M Tikly; B Hodkinson
Journal:  Rheumatol Int       Date:  2018-03-26       Impact factor: 2.631

Review 3.  Organ Damage and Quality of Life in Antiphospholipid Syndrome.

Authors:  P Alba; J A Gómez-Puerta; M V Goycochea-Robles; M C Amigo
Journal:  Curr Rheumatol Rep       Date:  2016-02       Impact factor: 4.592

4.  Linguistic Validation of the LupusQoL for the Assessment of Quality of Life in Iranian Patients with Systemic Lupus Erythematosus.

Authors:  Naeimehossadat Hosseini; Zahra Sayed Bonakdar; Ali Gholamrezaei; Leila Mirbagher
Journal:  Int J Rheumatol       Date:  2014-09-09

5.  Factors Associated with Health-Related Quality of Life in Mexican Lupus Patients Using the LupusQol.

Authors:  I Etchegaray-Morales; S Méndez-Martínez; C Jiménez-Hernández; C Mendoza-Pinto; N E Alonso-García; A Montiel-Jarquín; A López-Colombo; A García-Villaseñor; M H Cardiel; M García-Carrasco
Journal:  PLoS One       Date:  2017-01-23       Impact factor: 3.240

6.  Validation of the Malayalam Version of Leeds Assessment of Neuropathic Symptoms and Signs Pain Scale in Cancer Patients in the Regional Cancer Centre, Thiruvananthapuram, Kerala, India.

Authors:  Shoukkathali Anzar; Cherian Koshy; Kurian Mathew Abraham
Journal:  Indian J Palliat Care       Date:  2017 Jul-Sep

7.  Self-care agency in systemic lupus erythematosus and its associated factors: a cross-sectional study.

Authors:  Hui Yang; Xia Xie; Yuqing Song; Anliu Nie; Hong Chen
Journal:  Patient Prefer Adherence       Date:  2018-04-23       Impact factor: 2.711

8.  Measurement properties of selected patient-reported outcome measures for use in randomised controlled trials in patients with systemic lupus erythematosus: a systematic review.

Authors:  Vibeke Strand; Lee S Simon; Alexa Simon Meara; Zahi Touma
Journal:  Lupus Sci Med       Date:  2020-06

9.  Impact of demographic, clinical, and treatment compliance characteristics on quality of life of Venezuelan patients with systemic lupus erythematosus.

Authors:  Fhabián S Carrión-Nessi; María V Marcano-Rojas; Sinibaldo R Romero Arocha; Daniela L Mendoza Millán; David A Forero-Peña; Allen W Antuarez-Magallanes; Soham Al Snih; Martín A Rodríguez; Yurilís J Fuentes-Silva
Journal:  BMC Rheumatol       Date:  2022-01-04
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.